Clinical trials
Phase 1/2 Carcinoma, Renal Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
215 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 5 |
| 2001 | 3 |
| 2002 | 4 |
| 2003 | 2 |
| 2004 | 5 |
| 2005 | 9 |
| 2006 | 7 |
| 2007 | 3 |
| 2008 | 5 |
| 2009 | 5 |
| 2010 | 9 |
| 2011 | 3 |
| 2012 | 5 |
| 2013 | 4 |
| 2014 | 7 |
| 2015 | 8 |
| 2016 | 14 |
| 2017 | 15 |
| 2018 | 13 |
| 2019 | 7 |
| 2020 | 9 |
| 2021 | 16 |
| 2022 | 7 |
| 2023 | 16 |
| 2024 | 12 |
| 2025 | 10 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 82 |
| Terminated | 39 |
| Recruiting | 38 |
| Active, not recruiting | 21 |
| Unknown status | 21 |
| Withdrawn | 8 |
| Not yet recruiting | 4 |
| Suspended | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 15 |
| Incyte Biosciences International Sàrl | 5 |
| M.D. Anderson Cancer Center | 5 |
| Memorial Sloan Kettering Cancer Center | 5 |
| Merck Sharp & Dohme LLC | 5 |
| Fred Hutchinson Cancer Center | 4 |
| Regeneron Pharmaceuticals | 4 |
| Bristol-Myers Squibb | 3 |
| GI Innovation, Inc. | 3 |
| Pfizer | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Renal Cell | 215 |
| Carcinoma, Non-Small-Cell Lung | 58 |
| Melanoma | 52 |
| Kidney Neoplasms | 40 |
| Squamous Cell Carcinoma of Head and Neck | 30 |
| Colorectal Neoplasms | 28 |
| Neoplasm Metastasis | 28 |
| Stomach Neoplasms | 25 |
| Triple Negative Breast Neoplasms | 23 |
| Carcinoma, Hepatocellular | 22 |
Trials
Showing 51 to 75 of 215. Each trial links to its page on Pharma Observatory.
115 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.